Table 1.

Sensitivity analyses of efficacy of DCQD in intestinal obstruction

	Number of studies	Number of subjects	RR	95% CI	I2 value	NNT	95% CI
All studies#	6	361	1.13	0.97 to 1.31	58%	N/A	N/A
Risk of bias of trials
Moderate	5	301	1.14	0.95 to 1.39	66%	N/A	N/A
High	1	60	1.08	0.88 to 1.32	N/A	N/A	N/A
Route of administration
Via oral	4	231	1.08	0.84 to 1.39	67%	N/A	N/A
Via rectal	2	130	1.22	0.93 to 1.59	70%	N/A	N/A
Definition of response to therapy
Clinical alone	4	301	1.07	0.91 to 1.25	65%	N/A	N/A
Clinical + Imaging	2	60	1.45	1.11 to 1.91	0%	3.2	2 to 7.7
Aetiology
Postoperative	3	190	1.15	1.01 to 1.31	35%	7.7	4.2 to 50
Non-postoperative	3	171	1.11	0.72 to 1.73	78%	N/A	N/A

N/A, not applicable;

^#refers to the studies dichotomous data can be extracted from.